Related Funds
Funds with similar focus
Fund Name | Location |
9Point8 Capital | New York, New York, United States |
ADT Commercial | Boca Raton, Florida, United States |
Business Angels Club Aargau | Aargau, Brugg, Switzerland |
CIT Bank | Salt Lake City, United States, Utah |
Ever Sunny | China, Hong Kong, Hong Kong Island |
Foshan Damu Touzi | China, Foshan, Guangdong Province |
H20 Capital | - |
Huadao Investment Management | China, Jiangsu, Xuzhou |
Jincheng Dingsheng | China, Guangdong, Tianjin |
Koito | Chiyoda, Japan |
Link-U | Japan, Tokyo |
New Orleans Startup Fund | Louisiana, New Orleans, United States |
Now Capital | Delhi, India, New Delhi |
One Earth Capital | California, Felton, United States |
Pathway Bioventures | Chicago, Illinois, United States |
PR Times | Japan, Tokyo |
Secure Octane | California, San Francisco, United States |
Shihaisong Capital | - |
Temasek Holdings | Central Region, Singapore, Singapore |
Xfund | California, Palo Alto, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MedPlus | $89M | 10 Nov 2014 | India, Andhra Pradesh, India |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MedPlus | $89M | 10 Nov 2014 | India, Andhra Pradesh, India |